MedWatch

Pharma-boss: Big Pharma is copying biotech

A change in focus has major pharmaceutical companies looking towards the biotech industry, and the major corporations are copying the small biotechs in a number of ways.

20 years ago there was not the same focus on curing diseases in the pharmaceutical industry as there is today, according to Dr. Thomas Kerscher.

“It is not like that anymore. Today they go for the cure. Because there is still a lot of money to be made from a cure for, say, diabetes,” says the doctor, who is VP of Immunology and Respiratory in Takeda Pharmaceuticals.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier